Jacek Skarbinski to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications Jacek Skarbinski has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
Connection Strength
0.041
-
Rationale and design of the pragmatic randomized trial of icosapent ethyl for high cardiovascular risk adults (MITIGATE). Am Heart J. 2021 05; 235:54-64.
Score: 0.041